Imaging sensitive and drug-resistant bacterial infection with [11C]-trimethoprim

BACKGROUND. Several molecular imaging strategies can identify bacterial infections in humans. PET affords the potential for sensitive infection detection deep within the body. Among PET-based approaches, antibiotic-based radiotracers, which often target key bacterial-specific enzymes, have considera...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of clinical investigation 2022-09, Vol.132 (18), p.1-12
Hauptverfasser: Lee, Iris K., Jacome, Daniel A., Cho, Joshua K., Tu, Vincent, Young, Anthony J., Dominguez, Tiffany, Northrup, Justin D., Etersque, Jean M., Lee, Hsiaoju S., Ruff, Andrew, Aklilu, Ouniol, Bittinger, Kyle, Glaser, Laurel J., Dorgan, Daniel, Hadjiliadis, Denis, Kohli, Rahul M., Mach, Robert H., Mankoff, David A., Doot, Robert K., Sellmyer, Mark A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 12
container_issue 18
container_start_page 1
container_title The Journal of clinical investigation
container_volume 132
creator Lee, Iris K.
Jacome, Daniel A.
Cho, Joshua K.
Tu, Vincent
Young, Anthony J.
Dominguez, Tiffany
Northrup, Justin D.
Etersque, Jean M.
Lee, Hsiaoju S.
Ruff, Andrew
Aklilu, Ouniol
Bittinger, Kyle
Glaser, Laurel J.
Dorgan, Daniel
Hadjiliadis, Denis
Kohli, Rahul M.
Mach, Robert H.
Mankoff, David A.
Doot, Robert K.
Sellmyer, Mark A.
description BACKGROUND. Several molecular imaging strategies can identify bacterial infections in humans. PET affords the potential for sensitive infection detection deep within the body. Among PET-based approaches, antibiotic-based radiotracers, which often target key bacterial-specific enzymes, have considerable promise. One question for antibiotic radiotracers is whether antimicrobial resistance (AMR) reduces specific accumulation within bacteria, diminishing the predictive value of the diagnostic test. METHODS. Using a PET radiotracer based on the antibiotic trimethoprim (TMP), [11C]-TMP, we performed in vitro uptake studies in susceptible and drug-resistant bacterial strains and whole-genome sequencing (WGS) in selected strains to identify TMP resistance mechanisms. Next, we queried the NCBI database of annotated bacterial genomes for WT and resistant dihydrofolate reductase (DHFR) genes. Finally, we initiated a first-in-human protocol of ["C]-TMP in patients infected with both TMP-sensitive and TMP-resistant organisms to demonstrate the clinical feasibility of the tool. RESULTS. We observed robust ["C]-TMP uptake in our panel of TMP-sensitive and -resistant bacteria, noting relatively variable and decreased uptake in a few strains of P. aeruginosa and E. coli. WGS showed that the vast majority of clinically relevant bacteria harbor a WT copy of DHFR, targetable by ["C]-TMP, and that despite the AMR, these strains should be imageable. Clinical imaging of patients with [C]-TMP demonstrated focal radiotracer uptake in areas of infectious lesions. CONCLUSION. This work highlights an approach to imaging bacterial infection in patients, which could affect our understanding of bacterial pathogenesis as well as our ability to better diagnose infections and monitor response to therapy. TRIAL REGISTRATION. ClinicalTrials.gov NCT03424525. FUNDING. Institute for Translational Medicine and Therapeutics, Burroughs Wellcome Fund, NIH Office of the Director Early Independence Award (DP5-OD26386), and University of Pennsylvania NIH T32 Radiology Research Training Grant (5T32EB004311-12).
doi_str_mv 10.1172/JCI156679
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9479701</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2720978851</sourcerecordid><originalsourceid>FETCH-LOGICAL-c380t-2c3a95d967c6a19c87aad17d3006ce23498f32f7beb5ade89836fddbe08c4a2e3</originalsourceid><addsrcrecordid>eNpdkctKxDAUhoMoXkYXvkHBjS6qSdPmshFk8DIyoAtdiYQ0OZ2JdNIxSUd8ezsog7o6B87Hx3_4ETom-JwQXlzcjyekYozLLbRPqkrkoqBi-9e-hw5ifMOYlGVV7qI9yghmjIp99DhZ6JnzsyyCjy65FWTa28yGfpYHiC4m7VNWa5MgON1mzjdgkut89uHSPHshZPyap-AWkObdcpiHaKfRbYSjnzlCzzfXT-O7fPpwOxlfTXNDBU55YaiWlZWMG6aJNIJrbQm3FGNmoKClFA0tGl5DXWkLQgrKGmtrwMKUugA6Qpff3mVfL8Aa8CnoVq0j6PCpOu3U34t3czXrVkqWXHJMBsHpjyB07z3EpBYuGmhb7aHroyo4KVnFGSkH9OQf-tb1wQ_vDVSBJReiWgvPvikTuhgDNJswBKt1T2rTE_0C8yqE5w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2720978851</pqid></control><display><type>article</type><title>Imaging sensitive and drug-resistant bacterial infection with [11C]-trimethoprim</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Lee, Iris K. ; Jacome, Daniel A. ; Cho, Joshua K. ; Tu, Vincent ; Young, Anthony J. ; Dominguez, Tiffany ; Northrup, Justin D. ; Etersque, Jean M. ; Lee, Hsiaoju S. ; Ruff, Andrew ; Aklilu, Ouniol ; Bittinger, Kyle ; Glaser, Laurel J. ; Dorgan, Daniel ; Hadjiliadis, Denis ; Kohli, Rahul M. ; Mach, Robert H. ; Mankoff, David A. ; Doot, Robert K. ; Sellmyer, Mark A.</creator><creatorcontrib>Lee, Iris K. ; Jacome, Daniel A. ; Cho, Joshua K. ; Tu, Vincent ; Young, Anthony J. ; Dominguez, Tiffany ; Northrup, Justin D. ; Etersque, Jean M. ; Lee, Hsiaoju S. ; Ruff, Andrew ; Aklilu, Ouniol ; Bittinger, Kyle ; Glaser, Laurel J. ; Dorgan, Daniel ; Hadjiliadis, Denis ; Kohli, Rahul M. ; Mach, Robert H. ; Mankoff, David A. ; Doot, Robert K. ; Sellmyer, Mark A.</creatorcontrib><description>BACKGROUND. Several molecular imaging strategies can identify bacterial infections in humans. PET affords the potential for sensitive infection detection deep within the body. Among PET-based approaches, antibiotic-based radiotracers, which often target key bacterial-specific enzymes, have considerable promise. One question for antibiotic radiotracers is whether antimicrobial resistance (AMR) reduces specific accumulation within bacteria, diminishing the predictive value of the diagnostic test. METHODS. Using a PET radiotracer based on the antibiotic trimethoprim (TMP), [11C]-TMP, we performed in vitro uptake studies in susceptible and drug-resistant bacterial strains and whole-genome sequencing (WGS) in selected strains to identify TMP resistance mechanisms. Next, we queried the NCBI database of annotated bacterial genomes for WT and resistant dihydrofolate reductase (DHFR) genes. Finally, we initiated a first-in-human protocol of ["C]-TMP in patients infected with both TMP-sensitive and TMP-resistant organisms to demonstrate the clinical feasibility of the tool. RESULTS. We observed robust ["C]-TMP uptake in our panel of TMP-sensitive and -resistant bacteria, noting relatively variable and decreased uptake in a few strains of P. aeruginosa and E. coli. WGS showed that the vast majority of clinically relevant bacteria harbor a WT copy of DHFR, targetable by ["C]-TMP, and that despite the AMR, these strains should be imageable. Clinical imaging of patients with [C]-TMP demonstrated focal radiotracer uptake in areas of infectious lesions. CONCLUSION. This work highlights an approach to imaging bacterial infection in patients, which could affect our understanding of bacterial pathogenesis as well as our ability to better diagnose infections and monitor response to therapy. TRIAL REGISTRATION. ClinicalTrials.gov NCT03424525. FUNDING. Institute for Translational Medicine and Therapeutics, Burroughs Wellcome Fund, NIH Office of the Director Early Independence Award (DP5-OD26386), and University of Pennsylvania NIH T32 Radiology Research Training Grant (5T32EB004311-12).</description><identifier>ISSN: 1558-8238</identifier><identifier>ISSN: 0021-9738</identifier><identifier>EISSN: 1558-8238</identifier><identifier>DOI: 10.1172/JCI156679</identifier><identifier>PMID: 36106638</identifier><language>eng</language><publisher>Ann Arbor: American Society for Clinical Investigation</publisher><subject>Antibiotics ; Antimicrobial agents ; Antimicrobial resistance ; Bacteria ; Bacterial infections ; Binding sites ; Biomedical research ; Clinical Medicine ; Dihydrofolate reductase ; Drug dosages ; Drug resistance ; E coli ; Enzymes ; Feasibility studies ; Genes ; Genomes ; Infections ; Metabolism ; Patients ; Quality control ; Strains (organisms) ; Trimethoprim ; Whole genome sequencing</subject><ispartof>The Journal of clinical investigation, 2022-09, Vol.132 (18), p.1-12</ispartof><rights>Copyright American Society for Clinical Investigation Sep 2022</rights><rights>2022 Lee et al. 2022 Lee et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c380t-2c3a95d967c6a19c87aad17d3006ce23498f32f7beb5ade89836fddbe08c4a2e3</citedby><cites>FETCH-LOGICAL-c380t-2c3a95d967c6a19c87aad17d3006ce23498f32f7beb5ade89836fddbe08c4a2e3</cites><orcidid>0000-0003-3472-5934 ; 0000-0002-7689-5678 ; 0000-0003-3874-7321 ; 0000-0003-1747-239X ; 0000-0002-1407-1905</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479701/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479701/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Lee, Iris K.</creatorcontrib><creatorcontrib>Jacome, Daniel A.</creatorcontrib><creatorcontrib>Cho, Joshua K.</creatorcontrib><creatorcontrib>Tu, Vincent</creatorcontrib><creatorcontrib>Young, Anthony J.</creatorcontrib><creatorcontrib>Dominguez, Tiffany</creatorcontrib><creatorcontrib>Northrup, Justin D.</creatorcontrib><creatorcontrib>Etersque, Jean M.</creatorcontrib><creatorcontrib>Lee, Hsiaoju S.</creatorcontrib><creatorcontrib>Ruff, Andrew</creatorcontrib><creatorcontrib>Aklilu, Ouniol</creatorcontrib><creatorcontrib>Bittinger, Kyle</creatorcontrib><creatorcontrib>Glaser, Laurel J.</creatorcontrib><creatorcontrib>Dorgan, Daniel</creatorcontrib><creatorcontrib>Hadjiliadis, Denis</creatorcontrib><creatorcontrib>Kohli, Rahul M.</creatorcontrib><creatorcontrib>Mach, Robert H.</creatorcontrib><creatorcontrib>Mankoff, David A.</creatorcontrib><creatorcontrib>Doot, Robert K.</creatorcontrib><creatorcontrib>Sellmyer, Mark A.</creatorcontrib><title>Imaging sensitive and drug-resistant bacterial infection with [11C]-trimethoprim</title><title>The Journal of clinical investigation</title><description>BACKGROUND. Several molecular imaging strategies can identify bacterial infections in humans. PET affords the potential for sensitive infection detection deep within the body. Among PET-based approaches, antibiotic-based radiotracers, which often target key bacterial-specific enzymes, have considerable promise. One question for antibiotic radiotracers is whether antimicrobial resistance (AMR) reduces specific accumulation within bacteria, diminishing the predictive value of the diagnostic test. METHODS. Using a PET radiotracer based on the antibiotic trimethoprim (TMP), [11C]-TMP, we performed in vitro uptake studies in susceptible and drug-resistant bacterial strains and whole-genome sequencing (WGS) in selected strains to identify TMP resistance mechanisms. Next, we queried the NCBI database of annotated bacterial genomes for WT and resistant dihydrofolate reductase (DHFR) genes. Finally, we initiated a first-in-human protocol of ["C]-TMP in patients infected with both TMP-sensitive and TMP-resistant organisms to demonstrate the clinical feasibility of the tool. RESULTS. We observed robust ["C]-TMP uptake in our panel of TMP-sensitive and -resistant bacteria, noting relatively variable and decreased uptake in a few strains of P. aeruginosa and E. coli. WGS showed that the vast majority of clinically relevant bacteria harbor a WT copy of DHFR, targetable by ["C]-TMP, and that despite the AMR, these strains should be imageable. Clinical imaging of patients with [C]-TMP demonstrated focal radiotracer uptake in areas of infectious lesions. CONCLUSION. This work highlights an approach to imaging bacterial infection in patients, which could affect our understanding of bacterial pathogenesis as well as our ability to better diagnose infections and monitor response to therapy. TRIAL REGISTRATION. ClinicalTrials.gov NCT03424525. FUNDING. Institute for Translational Medicine and Therapeutics, Burroughs Wellcome Fund, NIH Office of the Director Early Independence Award (DP5-OD26386), and University of Pennsylvania NIH T32 Radiology Research Training Grant (5T32EB004311-12).</description><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Antimicrobial resistance</subject><subject>Bacteria</subject><subject>Bacterial infections</subject><subject>Binding sites</subject><subject>Biomedical research</subject><subject>Clinical Medicine</subject><subject>Dihydrofolate reductase</subject><subject>Drug dosages</subject><subject>Drug resistance</subject><subject>E coli</subject><subject>Enzymes</subject><subject>Feasibility studies</subject><subject>Genes</subject><subject>Genomes</subject><subject>Infections</subject><subject>Metabolism</subject><subject>Patients</subject><subject>Quality control</subject><subject>Strains (organisms)</subject><subject>Trimethoprim</subject><subject>Whole genome sequencing</subject><issn>1558-8238</issn><issn>0021-9738</issn><issn>1558-8238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkctKxDAUhoMoXkYXvkHBjS6qSdPmshFk8DIyoAtdiYQ0OZ2JdNIxSUd8ezsog7o6B87Hx3_4ETom-JwQXlzcjyekYozLLbRPqkrkoqBi-9e-hw5ifMOYlGVV7qI9yghmjIp99DhZ6JnzsyyCjy65FWTa28yGfpYHiC4m7VNWa5MgON1mzjdgkut89uHSPHshZPyap-AWkObdcpiHaKfRbYSjnzlCzzfXT-O7fPpwOxlfTXNDBU55YaiWlZWMG6aJNIJrbQm3FGNmoKClFA0tGl5DXWkLQgrKGmtrwMKUugA6Qpff3mVfL8Aa8CnoVq0j6PCpOu3U34t3czXrVkqWXHJMBsHpjyB07z3EpBYuGmhb7aHroyo4KVnFGSkH9OQf-tb1wQ_vDVSBJReiWgvPvikTuhgDNJswBKt1T2rTE_0C8yqE5w</recordid><startdate>20220915</startdate><enddate>20220915</enddate><creator>Lee, Iris K.</creator><creator>Jacome, Daniel A.</creator><creator>Cho, Joshua K.</creator><creator>Tu, Vincent</creator><creator>Young, Anthony J.</creator><creator>Dominguez, Tiffany</creator><creator>Northrup, Justin D.</creator><creator>Etersque, Jean M.</creator><creator>Lee, Hsiaoju S.</creator><creator>Ruff, Andrew</creator><creator>Aklilu, Ouniol</creator><creator>Bittinger, Kyle</creator><creator>Glaser, Laurel J.</creator><creator>Dorgan, Daniel</creator><creator>Hadjiliadis, Denis</creator><creator>Kohli, Rahul M.</creator><creator>Mach, Robert H.</creator><creator>Mankoff, David A.</creator><creator>Doot, Robert K.</creator><creator>Sellmyer, Mark A.</creator><general>American Society for Clinical Investigation</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>S0X</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3472-5934</orcidid><orcidid>https://orcid.org/0000-0002-7689-5678</orcidid><orcidid>https://orcid.org/0000-0003-3874-7321</orcidid><orcidid>https://orcid.org/0000-0003-1747-239X</orcidid><orcidid>https://orcid.org/0000-0002-1407-1905</orcidid></search><sort><creationdate>20220915</creationdate><title>Imaging sensitive and drug-resistant bacterial infection with [11C]-trimethoprim</title><author>Lee, Iris K. ; Jacome, Daniel A. ; Cho, Joshua K. ; Tu, Vincent ; Young, Anthony J. ; Dominguez, Tiffany ; Northrup, Justin D. ; Etersque, Jean M. ; Lee, Hsiaoju S. ; Ruff, Andrew ; Aklilu, Ouniol ; Bittinger, Kyle ; Glaser, Laurel J. ; Dorgan, Daniel ; Hadjiliadis, Denis ; Kohli, Rahul M. ; Mach, Robert H. ; Mankoff, David A. ; Doot, Robert K. ; Sellmyer, Mark A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c380t-2c3a95d967c6a19c87aad17d3006ce23498f32f7beb5ade89836fddbe08c4a2e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Antimicrobial resistance</topic><topic>Bacteria</topic><topic>Bacterial infections</topic><topic>Binding sites</topic><topic>Biomedical research</topic><topic>Clinical Medicine</topic><topic>Dihydrofolate reductase</topic><topic>Drug dosages</topic><topic>Drug resistance</topic><topic>E coli</topic><topic>Enzymes</topic><topic>Feasibility studies</topic><topic>Genes</topic><topic>Genomes</topic><topic>Infections</topic><topic>Metabolism</topic><topic>Patients</topic><topic>Quality control</topic><topic>Strains (organisms)</topic><topic>Trimethoprim</topic><topic>Whole genome sequencing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Iris K.</creatorcontrib><creatorcontrib>Jacome, Daniel A.</creatorcontrib><creatorcontrib>Cho, Joshua K.</creatorcontrib><creatorcontrib>Tu, Vincent</creatorcontrib><creatorcontrib>Young, Anthony J.</creatorcontrib><creatorcontrib>Dominguez, Tiffany</creatorcontrib><creatorcontrib>Northrup, Justin D.</creatorcontrib><creatorcontrib>Etersque, Jean M.</creatorcontrib><creatorcontrib>Lee, Hsiaoju S.</creatorcontrib><creatorcontrib>Ruff, Andrew</creatorcontrib><creatorcontrib>Aklilu, Ouniol</creatorcontrib><creatorcontrib>Bittinger, Kyle</creatorcontrib><creatorcontrib>Glaser, Laurel J.</creatorcontrib><creatorcontrib>Dorgan, Daniel</creatorcontrib><creatorcontrib>Hadjiliadis, Denis</creatorcontrib><creatorcontrib>Kohli, Rahul M.</creatorcontrib><creatorcontrib>Mach, Robert H.</creatorcontrib><creatorcontrib>Mankoff, David A.</creatorcontrib><creatorcontrib>Doot, Robert K.</creatorcontrib><creatorcontrib>Sellmyer, Mark A.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Iris K.</au><au>Jacome, Daniel A.</au><au>Cho, Joshua K.</au><au>Tu, Vincent</au><au>Young, Anthony J.</au><au>Dominguez, Tiffany</au><au>Northrup, Justin D.</au><au>Etersque, Jean M.</au><au>Lee, Hsiaoju S.</au><au>Ruff, Andrew</au><au>Aklilu, Ouniol</au><au>Bittinger, Kyle</au><au>Glaser, Laurel J.</au><au>Dorgan, Daniel</au><au>Hadjiliadis, Denis</au><au>Kohli, Rahul M.</au><au>Mach, Robert H.</au><au>Mankoff, David A.</au><au>Doot, Robert K.</au><au>Sellmyer, Mark A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Imaging sensitive and drug-resistant bacterial infection with [11C]-trimethoprim</atitle><jtitle>The Journal of clinical investigation</jtitle><date>2022-09-15</date><risdate>2022</risdate><volume>132</volume><issue>18</issue><spage>1</spage><epage>12</epage><pages>1-12</pages><issn>1558-8238</issn><issn>0021-9738</issn><eissn>1558-8238</eissn><abstract>BACKGROUND. Several molecular imaging strategies can identify bacterial infections in humans. PET affords the potential for sensitive infection detection deep within the body. Among PET-based approaches, antibiotic-based radiotracers, which often target key bacterial-specific enzymes, have considerable promise. One question for antibiotic radiotracers is whether antimicrobial resistance (AMR) reduces specific accumulation within bacteria, diminishing the predictive value of the diagnostic test. METHODS. Using a PET radiotracer based on the antibiotic trimethoprim (TMP), [11C]-TMP, we performed in vitro uptake studies in susceptible and drug-resistant bacterial strains and whole-genome sequencing (WGS) in selected strains to identify TMP resistance mechanisms. Next, we queried the NCBI database of annotated bacterial genomes for WT and resistant dihydrofolate reductase (DHFR) genes. Finally, we initiated a first-in-human protocol of ["C]-TMP in patients infected with both TMP-sensitive and TMP-resistant organisms to demonstrate the clinical feasibility of the tool. RESULTS. We observed robust ["C]-TMP uptake in our panel of TMP-sensitive and -resistant bacteria, noting relatively variable and decreased uptake in a few strains of P. aeruginosa and E. coli. WGS showed that the vast majority of clinically relevant bacteria harbor a WT copy of DHFR, targetable by ["C]-TMP, and that despite the AMR, these strains should be imageable. Clinical imaging of patients with [C]-TMP demonstrated focal radiotracer uptake in areas of infectious lesions. CONCLUSION. This work highlights an approach to imaging bacterial infection in patients, which could affect our understanding of bacterial pathogenesis as well as our ability to better diagnose infections and monitor response to therapy. TRIAL REGISTRATION. ClinicalTrials.gov NCT03424525. FUNDING. Institute for Translational Medicine and Therapeutics, Burroughs Wellcome Fund, NIH Office of the Director Early Independence Award (DP5-OD26386), and University of Pennsylvania NIH T32 Radiology Research Training Grant (5T32EB004311-12).</abstract><cop>Ann Arbor</cop><pub>American Society for Clinical Investigation</pub><pmid>36106638</pmid><doi>10.1172/JCI156679</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0003-3472-5934</orcidid><orcidid>https://orcid.org/0000-0002-7689-5678</orcidid><orcidid>https://orcid.org/0000-0003-3874-7321</orcidid><orcidid>https://orcid.org/0000-0003-1747-239X</orcidid><orcidid>https://orcid.org/0000-0002-1407-1905</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1558-8238
ispartof The Journal of clinical investigation, 2022-09, Vol.132 (18), p.1-12
issn 1558-8238
0021-9738
1558-8238
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9479701
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Antibiotics
Antimicrobial agents
Antimicrobial resistance
Bacteria
Bacterial infections
Binding sites
Biomedical research
Clinical Medicine
Dihydrofolate reductase
Drug dosages
Drug resistance
E coli
Enzymes
Feasibility studies
Genes
Genomes
Infections
Metabolism
Patients
Quality control
Strains (organisms)
Trimethoprim
Whole genome sequencing
title Imaging sensitive and drug-resistant bacterial infection with [11C]-trimethoprim
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T06%3A02%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Imaging%20sensitive%20and%20drug-resistant%20bacterial%20infection%20with%20%5B11C%5D-trimethoprim&rft.jtitle=The%20Journal%20of%20clinical%20investigation&rft.au=Lee,%20Iris%20K.&rft.date=2022-09-15&rft.volume=132&rft.issue=18&rft.spage=1&rft.epage=12&rft.pages=1-12&rft.issn=1558-8238&rft.eissn=1558-8238&rft_id=info:doi/10.1172/JCI156679&rft_dat=%3Cproquest_pubme%3E2720978851%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2720978851&rft_id=info:pmid/36106638&rfr_iscdi=true